Related content

Focal epithelial hyperplasia by human papillomavirus (HPV)‐32 misdiagnosed as HPV‐16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 12, 2015-12 ,pp. : 1172-1175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection

By Simen-Kapeu Aline   Kataja Vesa   Yliskoski Merja   Syrjanen Kari   Dillner Joakim   Koskela Pentti   Paavonen Jorma   Lehtinen Matti  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 9, 2008-01 ,pp. : 745-751

Informa Healthcare

Access to resources Recommend Favorite

Risk, choice and the ‘girl vaccine’: Unpacking human papillomavirus (HPV) immunisation

By Mishra Amrita   Graham Janice E.  

Health, Risk & Society, Vol. 14, Iss. 1, 2012-02 ,pp. : 57-69

Routledge Ltd

Access to resources Recommend Favorite

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

By Fastrez Maxime   Naik Haresh Nishan   Corfers Aurore   Rozenberg Serge  

Annals of Medicine, Vol. 44, Iss. 4, 2012-06 ,pp. : 404-404

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Hypnosis in the Treatment of Human Papillomavirus (HPV) in Women: Rural and Urban Samples

By Barabasz Arreed   Higley Linda   Christensen Ciara   Barabasz Marianne  

International Journal of Clinical and Experimental Hypnosis, Vol. 58, Iss. 1, 2010-01 ,pp. : 102-121

Routledge Ltd

Access to resources Recommend Favorite